SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-19-012072
Filing Date
2019-07-03
Accepted
2019-07-03 16:31:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs32019_anavexlifesciences.htm S-3 221721
2 OPINION OF SNELL & WILMER, L.L.P fs32019ex5-1_anavexlife.htm EX-5.1 9585
3 CONSENT OF BDO USA, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM fs32019ex23-1_anavexlife.htm EX-23.1 3075
  Complete submission text file 0001213900-19-012072.txt   235491
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-232550 | Film No.: 19942278
SIC: 8731 Services-Commercial Physical & Biological Research